Gene · 6555
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional Liposomes Improve the Oral Absorption of Lurasidone Hydrochloride by Overcoming Multiple Absorption Barriers and Eliminating Food Effect. | Int J Nanomedicine | 2025 | 40255673 | PubTator, text mining | PubMed |
| Alterations in intestinal bile acid transport provide a therapeutic target in patients with post-bariatric hypoglycaemia. | Nat Metab | 2025 | 40186075 | PubTator, text mining | PubMed |
| Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review. | Int J Mol Sci | 2025 | 40076514 | PubTator, text mining | PubMed |
| Cholestatic liver diseases: modern therapeutics. | Expert Rev Gastroenterol Hepatol | 2025 | 40011221 | PubTator, text mining | PubMed |
| Efficacy and safety of elobixibat in patients with chronic constipation-A randomized, multicenter, double-blind, placebo-controlled, parallel-group study from India. | Indian J Gastroenterol | 2025 | 39985701 | PubTator, text mining | PubMed |
| Effects of Four Main Active Flavonoids of Coreopsis tinctoria Nutt. on Oleic Acid-Induced Lipid Metabolism and Oxidative Stress in HepG2 Cells. | Discov Med | 2025 | 39973559 | PubTator, text mining | PubMed |
| Analysis of C4 Concentrations to Predict Impact of Patient-Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat. | CPT Pharmacometrics Syst Pharmacol | 2025 | 39945351 | PubTator, text mining | PubMed |
| Application of physiologically based (PBK) modeling to quantify the effect of the antibiotic tobramycin on bile acid levels in human plasma. | Arch Toxicol | 2025 | 39731603 | PubTator, text mining | PubMed |
| Exposure to triphenyl phosphate during pregnancy: The role of gut-bile acids-liver axis on lipid metabolism in male offspring. | Ecotoxicol Environ Saf | 2025 | 39693854 | PubTator, text mining | PubMed |
| Low polarity fraction of Radix Bupleuri alleviates chronic unpredictable mild stress-induced depression in rats through FXR modulating bile acid homeostasis in liver, gut, and brain. | J Pharm Biomed Anal | 2025 | 39489929 | PubTator, text mining | PubMed |
| Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls. | J Clin Endocrinol Metab | 2025 | 38636096 | PubTator, text mining | PubMed |
| Sympathetic innervation of interscapular brown adipose tissue is not a predominant mediator of Oxytocin (OT)-elicited reductions of body weight gain and adiposity in male diet-induced obese rats. | Front Drug Deliv | 2024 | 39866535 | PubTator, text mining | PubMed |
| [Systemic ASBT inhibition as a therapeutic target for cholestasis]. | Med Sci (Paris) | 2024 | 39656989 | PubTator, text mining | PubMed |
| Model predictive control based on single-phase shift modulation for triple active bridge DC-DC converter. | Sci Rep | 2024 | 39632904 | PubTator, text mining | PubMed |
| Sex differences and testosterone interfere with the structure of the gut microbiota through the bile acid signaling pathway. | Front Microbiol | 2024 | 39493843 | PubTator, text mining | PubMed |
| Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT. | J Med Chem | 2024 | 39419503 | PubTator, text mining | PubMed |
| RERconverge Expansion: Using Relative Evolutionary Rates to Study Complex Categorical Trait Evolution. | Mol Biol Evol | 2024 | 39404101 | PubTator, text mining | PubMed |
Integration of UPLC-MS/MS-based metabolomics and desorption electrospray ionization-mass spectrometry imaging reveals that Shouhui Tongbian Capsule alleviates slow transit constipation by regulating bile acid metabolism. | J Chromatogr B Analyt Technol Biomed Life Sci | 2024 | 39369590 | PubTator, text mining | PubMed |
| Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition. | Am J Physiol Gastrointest Liver Physiol | 2024 | 39350733 | PubTator, text mining | PubMed |
| Determination of Site-Specific Phosphorylation Occupancy Using Targeted Mass Spectrometry Reveals the Regulation of Human Apical Bile Acid Transporter, ASBT. | ACS Omega | 2024 | 39310206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6555/papers?page=4